Literature DB >> 22472353

Terson haemorrhage in patients suffering aneurysmal subarachnoid haemorrhage: a prospective analysis of 60 consecutive patients.

Martin N Stienen1, Sebastian Lücke, Oliver P Gautschi, Albrecht Harders.   

Abstract

OBJECTIVE: The concomitance of vitreous/subhyaloid haemorrhage (Terson syndrome; TS) and aneurysmal subarachnoid haemorrhage (aSAH) is commonly underestimated. The aim of this study was to determine the incidence of TS and to identify parameters that predispose its development, indicate the severity of the underlying disease, and predict outcome.
METHODS: Sixty consecutive patients suffering from aSAH were included in this study. The admitting Glasgow Coma Scale scores (GCS), Hunt & Hess (H&H) and Fisher grades were documented. All participants were ophthalmologically examined. The outcome at discharge was estimated using the Glasgow Outcome Scale (GOS).
RESULTS: Of the 60 patients admitted for aSAH, eleven (18.3%) displayed TS within 24h after aneurysm rupture. Statistical analysis revealed a significant relation between TS and either high Fisher- (3.0 vs. 2.32; p=0.008) or H&H- (4.09 vs. 2.69; p=0.001) and low GCS- (5.55 vs. 12.87; p<0.001) scores. Compared with the non-TS group, patients with TS displayed generally worse outcomes (mean GOS 2.09 vs. 3.53; p=0.007), including a significantly higher mortality (36.4 vs. 10.2%; p=0.028).
CONCLUSION: Terson syndrome is likely to occur in severe aSAH with poor admission scores and indicates a worse functional outcome. An ophthalmological examination is strongly recommended in aSAH patients with poor admission scores.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22472353     DOI: 10.1016/j.clineuro.2011.10.034

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  9 in total

1.  Terson syndrome in conjunction with ruptured intracranial aneurysm and penetrating intracranial injury: a review of two cases.

Authors:  Matt Rheinboldt; Kirenza Francis; David Parrish; Derrick Harper; John Blase
Journal:  Emerg Radiol       Date:  2013-10-31

2.  Early Intraocular Complications of Subarachnoid Haemorrhage after Aneurysm Rupture.

Authors:  Iwona Obuchowska; Grzegorz Turek; Zenon Mariak; Zofia Mariak
Journal:  Neuroophthalmology       Date:  2014-06-18

3.  25G compared with 20G vitrectomy under Resight non-contact wide-angle lenses for Terson syndrome.

Authors:  Xinbang Mao; Zhipeng You
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

4.  Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury.

Authors:  Patrick Czorlich; Christos Skevas; Volker Knospe; Eik Vettorazzi; Gisbert Richard; Lars Wagenfeld; Manfred Westphal; Jan Regelsberger
Journal:  Neurosurg Rev       Date:  2014-08-31       Impact factor: 3.042

5.  Blind spot: blindness as initial presentation of subarachnoid haemorrhage.

Authors:  André Leonardo Gordinho; Steeve Rosado; Teresa Mesquita; Nuno Ribeiro Ferreira
Journal:  BMJ Case Rep       Date:  2018-04-10

6.  Multilayered macular hemorrhages as an unusual complication of transorbital neuroendoscopic surgery.

Authors:  William Foulsham; Victoria S North; Benjamin W Botsford; Marc J Dinkin; Fraser Henderson; Kyle J Godfrey; Donald J D'Amico; Theodore H Schwartz; Anton Orlin
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-23

7.  Practical Incidence and Risk Factors of Terson's Syndrome: A Retrospective Analysis in 322 Consecutive Patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Gun-Ill Lee; Kyu-Sun Choi; Myung-Hoon Han; Hyoung-Soo Byoun; Hyeong-Joong Yi; Byung-Ro Lee
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2015-09-30

8.  Terson's Syndrome - case report.

Authors:  Andreea Moraru; Ruxandra Mihailovici; Dănuţ Costin; Daniel Brănişteanu
Journal:  Rom J Ophthalmol       Date:  2017 Jan-Mar

Review 9.  An explanation for Terson syndrome at last: the glymphatic reflux theory.

Authors:  Ashwin Kumaria; Anna M Gruener; Graham R Dow; Stuart J Smith; Donald C Macarthur; Harshal A Ingale
Journal:  J Neurol       Date:  2021-06-25       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.